Takara Holdings Inc 2018 Integrated Report
The report presents Takara Holdings' fiscal 2018 integrated results, including record consolidated net sales of ¥268,142 million. It reports Group-wide production-process CO2 emissions of 108.93 thousand t-CO2 and water usage of 6.11 million m3. The report also describes initiatives to reduce environmental impacts, including greenhouse gas emissions, water use and waste. In its biomedical business, Takara Bio advances gene-therapy development and expands regenerative-medicine manufacturing capabilities.
Company: Takara Holdings Inc
Sector: Manufacturing
Country: Japan
Year: 2018
Type: Integrated Report
Pages: 30
Takara Holdings Inc
The report presents Takara Holdings' fiscal 2018 integrated results, including record consolidated net sales of ¥268,142 million. It reports Group-wide production-process CO2 emissions of 108.93 thousand t-CO2 and water usage of 6.11 million m3. The report also describes initiatives to reduce environmental impacts, including greenhouse gas emissions, water use and waste. In its biomedical business, Takara Bio advances gene-therapy development and expands regenerative-medicine manufacturing capabilities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Apr 1, 2017 - Mar 31, 2018
Fiscal Year
2018
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption